Related references
Note: Only part of the references are listed.Therapeutic potential of Galectin-9 in human disease
Valerie R. Wiersma et al.
MEDICINAL RESEARCH REVIEWS (2013)
Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
Yang Cao et al.
PLOS ONE (2013)
Tim-3 Expression Defines Regulatory T Cells in Human Tumors
Jing Yan et al.
PLOS ONE (2013)
Galectin-9 in Cancer Therapy
Shintaro Fujihara et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2013)
Ectopic Expression of TIM-3 in Lung Cancers A Potential Independent Prognostic Factor for Patients With NSCLC
Xuewei Zhuang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
Zhao-Yang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells
Rachelle G. Veenstra et al.
BLOOD (2012)
Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
Takeshi Kadowaki et al.
CLINICAL IMMUNOLOGY (2012)
The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
Valerie R. Wiersma et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes
Ying Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
Freddie Bray et al.
LANCET ONCOLOGY (2012)
Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity
Gisela M. Vaitaitis et al.
PLOS ONE (2012)
Galectin-9 Ameliorates Con A-Induced Hepatitis by Inducing CD4+CD25low/int Effector T-Cell Apoptosis and Increasing Regulatory T Cell Number
Kun Lv et al.
PLOS ONE (2012)
Prospects for TIM3-Targeted Antitumor Immunotherapy
Shin Foong Ngiow et al.
CANCER RESEARCH (2011)
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
Masafumi Nakayama et al.
BLOOD (2009)
Role of Tim-3/Galectin-9 Inhibitory Interaction in Viral-Induced Immunopathology: Shifting the Balance toward Regulators'
Sharvan Sehrawat et al.
JOURNAL OF IMMUNOLOGY (2009)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
Atsuya Nobumoto et al.
GLYCOBIOLOGY (2008)
Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma
Meiyan Liang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
TIMs: central regulators of immune responses
David A. Hafler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells
Zoltan Wiener et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
Cecile Keryer-Bibens et al.
BMC CANCER (2006)
Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer
Akira Yamauchi et al.
BREAST JOURNAL (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer
A Irie et al.
CLINICAL CANCER RESEARCH (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway
Y Kashio et al.
JOURNAL OF IMMUNOLOGY (2003)
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance
CA Sabatos et al.
NATURE IMMUNOLOGY (2003)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Increased galectin-3 expression in gastric cancer:: Correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation
SE Baldus et al.
TUMOR BIOLOGY (2000)
Share Paper
